Insufficient scRNA-seq data for expression of PIWIL2 at single-cell level.
Insufficient scRNA-seq data for expression of PIWIL2 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
intestine | 99% | 201.73 | 954 / 966 | 76% | 2.93 | 400 / 527 |
stomach | 96% | 134.58 | 344 / 359 | 77% | 3.41 | 219 / 286 |
pancreas | 100% | 371.98 | 327 / 328 | 57% | 1.52 | 101 / 178 |
bladder | 90% | 207.95 | 19 / 21 | 28% | 1.33 | 143 / 504 |
liver | 95% | 119.03 | 215 / 226 | 23% | 0.48 | 94 / 406 |
brain | 87% | 141.95 | 2291 / 2642 | 31% | 0.68 | 217 / 705 |
prostate | 99% | 237.37 | 242 / 245 | 16% | 0.31 | 81 / 502 |
breast | 100% | 308.67 | 458 / 459 | 13% | 0.63 | 145 / 1118 |
uterus | 99% | 318.91 | 168 / 170 | 12% | 0.79 | 54 / 459 |
thymus | 94% | 138.49 | 614 / 653 | 12% | 0.33 | 70 / 605 |
ovary | 100% | 368.32 | 180 / 180 | 4% | 0.06 | 18 / 430 |
ureter | 0% | 0 | 0 / 0 | 100% | 2.30 | 1 / 1 |
adipose | 98% | 243.68 | 1178 / 1204 | 0% | 0 | 0 / 0 |
skin | 91% | 173.43 | 1640 / 1809 | 6% | 0.18 | 29 / 472 |
blood vessel | 97% | 221.29 | 1292 / 1335 | 0% | 0 | 0 / 0 |
lung | 78% | 82.47 | 450 / 578 | 18% | 0.93 | 203 / 1155 |
muscle | 95% | 361.52 | 760 / 803 | 0% | 0 | 0 / 0 |
esophagus | 65% | 90.68 | 939 / 1445 | 28% | 1.35 | 52 / 183 |
spleen | 84% | 89.26 | 202 / 241 | 0% | 0 | 0 / 0 |
kidney | 66% | 60.84 | 59 / 89 | 8% | 0.17 | 71 / 901 |
heart | 59% | 69.75 | 504 / 861 | 0% | 0 | 0 / 0 |
adrenal gland | 24% | 18.55 | 62 / 258 | 8% | 0.61 | 19 / 230 |
tonsil | 0% | 0 | 0 / 0 | 22% | 1.61 | 10 / 45 |
eye | 0% | 0 | 0 / 0 | 3% | 0.17 | 2 / 80 |
peripheral blood | 1% | 0.74 | 8 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0141005 | Biological process | retrotransposon silencing by heterochromatin formation |
GO_2000767 | Biological process | positive regulation of cytoplasmic translation |
GO_0007283 | Biological process | spermatogenesis |
GO_0141006 | Biological process | piRNA-mediated retrotransposon silencing by heterochromatin formation |
GO_0141008 | Biological process | retrotransposon silencing by mRNA destabilization |
GO_0140965 | Biological process | secondary piRNA processing |
GO_0141007 | Biological process | siRNA-mediated retrotransposon silencing by heterochromatin formation |
GO_0060903 | Biological process | positive regulation of meiosis I |
GO_0051321 | Biological process | meiotic cell cycle |
GO_0042754 | Biological process | negative regulation of circadian rhythm |
GO_0031047 | Biological process | regulatory ncRNA-mediated gene silencing |
GO_0048477 | Biological process | oogenesis |
GO_0048511 | Biological process | rhythmic process |
GO_0030718 | Biological process | germ-line stem cell population maintenance |
GO_0043186 | Cellular component | P granule |
GO_0010370 | Cellular component | perinucleolar chromocenter |
GO_1990923 | Cellular component | PET complex |
GO_0071546 | Cellular component | pi-body |
GO_0033391 | Cellular component | chromatoid body |
GO_0097433 | Cellular component | dense body |
GO_0005737 | Cellular component | cytoplasm |
GO_0005634 | Cellular component | nucleus |
GO_0004521 | Molecular function | RNA endonuclease activity |
GO_0003729 | Molecular function | mRNA binding |
GO_0034584 | Molecular function | piRNA binding |
GO_0046872 | Molecular function | metal ion binding |
GO_0005515 | Molecular function | protein binding |
Gene name | PIWIL2 |
Protein name | Piwi-like protein 2 Piwi-like protein 2 (EC 3.1.26.-) (Cancer/testis antigen 80) (CT80) Piwi-like RNA-mediated gene silencing 2 |
Synonyms | HILI |
Description | FUNCTION: Endoribonuclease that plays a central role during spermatogenesis by repressing transposable elements and preventing their mobilization, which is essential for the germline integrity (By similarity). Plays an essential role in meiotic differentiation of spermatocytes, germ cell differentiation and in self-renewal of spermatogonial stem cells (By similarity). Acts via the piRNA metabolic process, which mediates the repression of transposable elements during meiosis by forming complexes composed of piRNAs and Piwi proteins and govern the methylation and subsequent repression of transposons (By similarity). During piRNA biosynthesis, plays a key role in the piRNA amplification loop, also named ping-pong amplification cycle, by acting as a 'slicer-competent' piRNA endoribonuclease that cleaves primary piRNAs, which are then loaded onto 'slicer-incompetent' PIWIL4 (By similarity). PIWIL2 slicing produces a pre-miRNA intermediate, which is then processed in mature piRNAs, and as well as a 16 nucleotide by-product that is degraded (By similarity). Required for PIWIL4/MIWI2 nuclear localization and association with secondary piRNAs antisense (By similarity). Besides their function in transposable elements repression, piRNAs are probably involved in other processes during meiosis such as translation regulation (By similarity). Indirectly modulates expression of genes such as PDGFRB, SLC2A1, ITGA6, GJA7, THY1, CD9 and STRA8 (By similarity). When overexpressed, acts as an oncogene by inhibition of apoptosis and promotion of proliferation in tumors . Represses circadian rhythms by promoting the stability and activity of core clock components BMAL1 and CLOCK by inhibiting GSK3B-mediated phosphorylation and ubiquitination-dependent degradation of these proteins . . |
Accessions | Q8TC59 ENST00000611073.1 [Q8TC59-2] A0A059V6Y7 ENST00000356766.11 [Q8TC59-1] ENST00000521356.5 [Q8TC59-2] W0HK13 ENST00000454009.6 [Q8TC59-1] |